ArticleJournal of oncology2022

SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer.

Pengcheng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.